SOX18 and neoplasm: The finding of its expression in a number of tumor cell lines [19], the observation that ragged mice show reduced growth of vascularized tumors [20], and the successful inhibition of tumor angiogenesis using cell-permeable dn SOX18 mutants [21] support the view that SOX18 could be a valuable target for interfering with (tumor) angiogenesis.